ResearchMoz

Dysphagia Global Clinical Trials Review, Q1, 2011

Publisher Name » GlobalData
Published Date » 2011-03-15
No. Of Pages » 47

GlobalData's clinical trial report, “Dysphagia Global Clinical Trials Review, Q1, 2011 provides data on the Dysphagia clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Dysphagia. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Dysphagia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Dysphagia 6
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Unaccomplished Trials of Dysphagia 18
Subjects Recruited Over a Period of Time 19
Prominent Sponsors 20
Prominent Drug Comparison 22
Clinical Trial Profiles 23
Clinical Trial Overview of Top Universities / Institutes / Hospitals 23
National Taiwan University Hospital 23
Clinical Trial Overview of National Taiwan University Hospital 23
University of California, Davis 24
Clinical Trial Overview of University of California, Davis 24
University of Canterbury 25
Clinical Trial Overview of University of Canterbury 25
Nepean Hospital 26
Clinical Trial Overview of Nepean Hospital 26
Nestle HealthCare Nutrition 27
Clinical Trial Overview of Nestle HealthCare Nutrition 27
National Stroke Foundation 28
Clinical Trial Overview of National Stroke Foundation 28
Ostfold Hospital Trust 29
Clinical Trial Overview of Ostfold Hospital Trust 29
Health Research Council of New Zealand 30
Clinical Trial Overview of Health Research Council of New Zealand 30
University of Munster 31
Clinical Trial Overview of University of Munster 31
Sir Charles Gairdner Hospital 32
Clinical Trial Overview of Sir Charles Gairdner Hospital 32
Royal Adelaide Hospital 33
Clinical Trial Overview of Royal Adelaide Hospital 33
Les Hopitaux Universitaires de Strasbourg 34
Clinical Trial Overview of Les Hopitaux Universitaires de Strasbourg 34
China Medical University Hospital 35
Clinical Trial Overview of China Medical University Hospital 35
Hillel Yaffe Medical Center 36
Clinical Trial Overview of Hillel Yaffe Medical Center 36
Rouen University Hospital 37
Clinical Trial Overview of Rouen University Hospital 37
University Health Network 38
Clinical Trial Overview of University Health Network 38
University of Louisville 39
Clinical Trial Overview of University of Louisville 39
National Institute of Neurological Disorders and Stroke 40
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 40
University of Florida 41
Clinical Trial Overview of University of Florida 41
Norwegian University of Science and Technology 42
Clinical Trial Overview of Norwegian University of Science and Technology 42
Department of Veterans Affairs 43
Clinical Trial Overview of Department of Veterans Affairs 43

Appendix 44
Abbreviations 44
Definitions 44
Research Methodology 45
Secondary Research 46
About GlobalData 46
Contact Us 46
Disclaimer 47
Source 47

List of Tables


Dysphagia Therapeutics Market, Global, Clinical Trials by Zone, 2011* 8
Dysphagia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Dysphagia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Dysphagia Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2011* 11
Dysphagia Therapeutics Clinical Trials, Europe, Top Countries, 2011* 12
Dysphagia Therapeutics Clinical Trials, North America, Top Countries, 2011* 13
Dysphagia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 14
Dysphagia Therapeutics Market, Global, Clinical Trials by Phase, 2011* 15
Dysphagia Therapeutics Market, Global, Clinical Trials in Progress by Phase 2011* 16
Dysphagia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 17
Dysphagia Therapeutics Market, Global, Suspended Clinical Trials, 2011* 18
Dysphagia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Dysphagia Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 21
Dysphagia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011** 22
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2011* 23
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2011* 24
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Canterbury, 2011* 25
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nepean Hospital, 2011* 26
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle HealthCare Nutrition, 2011* 27
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Stroke Foundation, 2011* 28
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ostfold Hospital Trust, 2011* 29
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Research Council of New Zealand, 2011* 30
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Munster, 2011* 31
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sir Charles Gairdner Hospital, 2011* 32
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Adelaide Hospital, 2011* 33
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Hopitaux Universitaires de Strasbourg, 2011* 34
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by China Medical University Hospital, 2011* 35
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hillel Yaffe Medical Center, 2011* 36
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2011* 37
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2011* 38
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Louisville, 2011* 39
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2011* 40
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2011* 41
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2011* 42
Dysphagia Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Veterans Affairs, 2011* 43

List of Figures


Dysphagia Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 8
Dysphagia Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Dysphagia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Dysphagia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 11
Dysphagia Therapeutics Clinical Trials, Europe, Top Countries (%), 2011* 12
Dysphagia Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 13
Dysphagia Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 15
Dysphagia Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2011* 16
Dysphagia Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 17
Dysphagia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Dysphagia Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 20
Dysphagia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 22
GlobalData Methodology 45

Upcoming Reports:

Treatments For Neurodegenerative Disorders - Global Forecast, Market Share, Size, Growth And Industry Analysis, 2012 - 2018
By - Transparency Market Research
Neurodegenerative disorders cause progressive loss of function structure of the neurons in the human brain. The most commonly known neurodegenerative diseases are Alzheimer’s, Parkinson’s, Amyotrophic lateral sclerosis, and Huntington’s Syndrome. Most neurodegenerative disorders are caused because of genetic mutation in completely unrelated cells. Increase in the awareness regarding mental disorders and the rise in research and development regarding the treatment of such disorders are the major factors that are driving the growth of this market. However, despite...
Global Contrast Media/Contrast Agents Market - Global Industry Analysis, Size, Growth, Share, and Forecast, 2012 - 2018
By - Transparency Market Research
Contrast media or contrast agents provide better images of anatomical structures since they increase the image contrast, thus providing better images of body structures and organs. These agents are helpful in providing better visualization of body structures during several medical procedures such as computed tomography (CT), X-ray, catheterization laboratory (cath lab), and ultrasound and magnetic resonance imaging (MRI). North America accounts for the highest share in global contrast media/ contrast agents market followed by Europe. The reason for North America and Europe...
Monoclonal Antibodies Market - Global Industry Size, Share, Trends, Analysis and Forecast, 2012 - 2018
By - Transparency Market Research
Monoclonal antibodies have brought a paradigm shift in biotechnology and pharmaceutical sectors. Monoclonal antibodies (mAbs) are mono-specific antibodies which comprise of identical immune cells and these immune cells are clones of a single parent cell and are distinguished by their unique property to bind to the same epitope .  Monoclonal antibodies are now used for treatment of a wide array of diseases, especially cancer, autoimmune, and inflammatory diseases. The development of these new molecular agents, successfully directed to specific cellular targets, is...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...